Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Embecta Corp.

Wall Street Turned Bearish on Embecta After a “Major Miss” Exposed the Gap Between Management’s “Incredibly Resolute” Pen Needle Claims and a 57.8%...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	EMBC	$4.42	+26.29%	5.59M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	EMBC	$4.42	+26.3%	5.59M
3
4
5
6

EMBC

EMBC

Get Embecta Corp. Data in Excel

Get Embecta Corp. Data in Excel